Diabetes Industry Global Dashboard
The Diabetes Industry Global Dashboard presents key insights with 2,760 companies, 1,070 investors, 1,735 funding rounds, and 2,025 clinical trials. The Funding Distribution shows most companies receiving funding below $1M to $10M, while fewer companies secured amounts exceeding $500M. The Geographical Distribution highlights Europe leading with 57.45%, followed by North America (31.91%) and Asia (9.57%).
2760
Companies
1070
Investors
1735
Funding Rounds
2025
Clinical Trials
Diabetes Industry in Gulf Cooperation Council
Key Metrics - The Diabetes Industry in Gulf Cooperation Council dashboard provides insights into 58 companies, 9 investors, 66 clinical trials, and 20 funding rounds across the region.
Industry Categories - Companies are distributed across four main sectors: Biotech, IT Service, R&D, and Service, highlighting their contributions to the diabetes industry.
Diabetes Industry Global Circular Universe
-
Key Metrics:
The Global Diabetes Industry Overview 2023 visually maps thousands of companies, investors, and R&D centers within the diabetes sector. -
Central Structure:
The core highlights key R&D Centers, Investors, and Companies, representing the foundational infrastructure of the diabetes industry ecosystem. -
Industry Categories:
The circular chart is segmented into diverse categories, including Diabetes Prevention, Diabetes Treatment, Devices (Glucose Monitoring), Diabetes Management, and other specialized subsectors like Rehabilitation and Healthy Nutrition.